APOE and Alzheimer disease: The lack of differences in CSF lipoprotein-associated APOE levels aligns with our CSF biochemical analyses and those of Martinez-Morillo et al. (45), who also observed no difference in CSF APOE levels between patients with AD and non-AD patients when measured by mass spectrometry.